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1ABSTRACT
Apolipoprotein A-I (ApoA-I) is associated with high-density lipoprotein (HDL). 
ApoA-I is best known for its role in reverse cholesterol transport. Recent studies in 
mammals and fishes have reported antibacterial, antiviral, and anti-inflammatory 
activities o f HDL and ApoA-I. The goals o f the present study were: to purify ApoA-I 
from striped bass plasma, obtain sequence information from the striped bass ApoA-I 
gene, investigate the antibacterial activity of striped bass ApoA-I against one gram- 
positive bacteria {Streptococcus sp.), one species o f gram-negative bacteria {E. coli), and 
one species of mycobacteria {Mycobacterium marinum) in vitro, and finally evaluate the 
role o f diet in regulation of ApoA-I in vivo. Striped bass ApoA-I was purified from 
plasma using Affi-gel Blue affinity chromatography to isolate HDL, followed by 
delipidation to remove HDL associated lipoproteins from HDL lipid, and then ApoA-I 
was separated from other proteins using gel filtration chromatography. Two-dimensional 
electrophoresis was used to help characterize the purified protein as approximately 25kD 
in size with an acidic pi o f approximately 5.0. The monoclonal antibody 6 D 6  recognized 
the 25kD protein and N-terminal sequencing generated a 25 amino acid sequence highly 
similar to other fish ApoA-I sequences. The ApoA-I gene was sequenced from both 
genomic striped bass DNA isolated from spleen, and liver cDNA. The resulting 
sequence containing the coding region o f the gene is approximately 1240 bp. The 
translated protein is 275 amino acids long and is similar to other ApoA-I fish sequences. 
The predicted secondary and tertiary structure is highly conserved in ApoA-I sequences 
of both mammals and fishes and contains characteristic proline kinks spaced 2 2  and 1 1  
amino acids apart as well as (-helical characteristics. Purified ApoA-I exhibited 
antibacterial activity against E. coli. Streptococcus sp., and M. marinum using a micro 
titer broth dilution assay. Concentrations as low as 125 fg/ml for£ . coli, 250 fg/ml for 
Streptococcus sp., and 250 fg/ml for M. marinum, inhibited bacterial growth by 50% 
compared to control. ApoA-I plasma concentrations in experimental fish and wild fish 
tested ranged from 0.5-5 mg/ml or more, which is greater than in vitro concentrations 
used in assays.
ApoA-I is regulated by fat obtained in the diet o f mammals. In mammals, low-fat 
diets and starvation diets result in reduced levels o f HDL and associated ApoA-I. We 
studied two groups ( 2 2  fish each) of juvenile striped bass fed either a high fat diet (8 % 
menhaden oil) or a low fat diet (0% menhaden oil) over a period of 120 days. However, 
no significant differences in growth or ApoA-I plasma concentrations were observed 
between the high fat and low fat groups.
Results o f our studies indicate that striped bass ApoA-I is an effective 
antibacterial agent against E. coli, Streptococcus sp., and M. marinum in vitro at 
concentrations below the range o f physiological concentrations in striped bass plasma. 
Therefore we speculate that ApoA-I could play a role in defense against infections with 
these bacteria in striped bass. Further studies are needed to isolate the mechanism of 
antibacterial activity, and determine how the protein may act in vivo.
2GENERAL INTRODUCTION
Striped Bass Diet
Striped bass are generalist, carnivorous fish, consuming small fishes, crustaceans, 
squid, shellfish, and worms (Raney 1952). Larger striped bass prefer a piscivorous diet, 
consisting mainly of silversides (Menidia menidia), Atlantic menhaden (Brevoortia 
tyrannus), bay anchovy (Anchoa mitchilli), spot (Leiostomus xanthurus), Atlantic croaker 
(Micropogonias undulates), and killifishes (Fundulus spp.) (Raney 1952). Between 1990 
and 1992, Chesapeake Bay striped bass diet was dominated by a few prey species, and 
the relative dominance o f these species changed with predator age and size (Hartman and 
Brandt 1995). Bay anchovy were the dominant prey found in stomach contents of young 
fish (age 1) while older individuals (age 2+) fed on Atlantic menhaden, spot, and Atlantic 
croakers (Hartman and Brandt 1995). Atlantic menhaden became increasingly important 
in the diet of older fish and contributed up to 60% of the diet from September to 
December, when much o f the annual growth o f striped bass occurs (Hartman and Brandt 
1995).
As the Chesapeake Bay stocks o f striped bass began to rebound after a moratorium 
on fishing in the late 1980s (Figure 1 and 2), the demand for Atlantic menhaden by 
striped bass increased. By the late 1990s the ratio o f striped bass to menhaden reached 
their lowest levels at 49 menhaden per kg of striped bass, from previous levels of 1700 
menhaden per kg of striped bass in the early 1980s (Uphoff 2003). Analysis of 1997 diet 
data o f large striped bass (458-1151mm, 0.91-17.6 kg) indicates menhaden accounted for 
44% by weight and occurred in 18% of all stomachs (Walter and Austin 2003). Recent
3studies, however, have suggested a more significant absence of menhaden in the diet of 
Chesapeake Bay striped bass (McNamee personal communication).
Infectious Diseases of Striped Bass
A variety of pathogens affect the health of striped bass (Morone saxatilis) in the wild 
and in aquaculture. Common bacterial diseases include vibriosis, aeromonad infections, 
pasteurellosis, edwarsiellosis, flavobacteriosis, streptococcosis, myxobacterial infection, 
bacterial kidney disease, and mycobacteriosis (Frerichs 1989; Hughes et al. 1990; Plumb 
1991). Most of these infections have been reported in cultured populations of striped 
bass; however several of these bacteria species including Pasteurella piscicida, 
Mycobacterium marinum, Streptococcus spp., and Edwardsiella sp. have been associated 
with epizootics in wild populations (Baya et al. 1990, 1997; Hughes et al. 1990; Sakanari 
et al. 1983; Sniezsko et al. 1964; Vogelbein et al. 1999). Outbreaks o f bacterial 
infections have recently occurred in the Chesapeake Bay striped bass. Mortalities of 
striped bass in Maryland in 1988 were associated with Streptococcus sp. (Baya et al.
1990) and in 1994, Edwardsiella tarda was associated with lesions o f the skin and 
internal organs (Baya et al. 1997).
In 1997, Mycobacterium sp. was identified in Chesapeake Bay striped bass by 
histology in association with skin and visceral lesions (Vogelbein et al. 1999; Cardinal 
2001). Visceral and dermal lesions prevalence of 62.7% and 28.8%, respectively, have 
been recorded from Virginia tributaries o f the Chesapeake Bay (Cardinal, 2001). A 
survey of striped bass in the Maryland portion o f the Chesapeake Bay has indicated a 
high prevalence o f splenic granulomas associated with mycobacteria (Overton et al. 
2003).
4The only other previously reported outbreak of mycobacteriosis in wild striped bass 
occurred in fish from four areas in northern California and in Coos Bay, Oregon, in 1983 
(Sakanari et al. 1983). These fish exhibited granulomatous lesions in spleen, kidney, 
and/or liver.
Mycobacteria
Mycobacteria are gram-positive staining, acid-fast, aerobic, non-motile, rod-shaped 
bacteria. They are distinct from other gram-positive aerobes because of the high content 
of mycolic acids and free lipids as well as waxy fatty acids contained in the cell wall 
(Pfyffer et al. 2003). Species of mycobacteria are classified as either slow-growers, or 
fast growers requiring more or less than seven days to form colonies on agar (Pfyffer et 
al. 2003). The majority of pathogenic mycobacteria are intracellular parasites of 
macrophages.
Mycobacteriosis in fishes
External clinical signs of mycobacteriosis in fishes include scale loss, dermal 
ulceration, emaciation, exophthalmia, pigmentation changes and spinal defects (Nigrelli 
and Vogel 1963; Gomez et al. 1993). Internal gross pathologies include enlargement o f 
the spleen, kidney, and liver with grey or white nodules throughout the affected organs 
(Chinabut 1999).
As o f 1963, 150 species of fish have been described as being affected by 
mycobacteriosis (Nigrelli and Vogel, 1963) and the list is still growing. Mycobacterium 
marinum, fortuitum, and chelonae are species of mycobacteria that infect both freshwater 
and saltwater fish worldwide (Herbst et al. 2001; Lansdell et al. 1993; Pfyffer et al. 2003; 
Tortoli et al. 1996). Recently two additional novel species of slow-growing mycobacteria
5have been described in association with striped bass mycobacteriosis in the Chesapeake 
Bay (Rhodes et al. 2001, 2003).
Polyunsaturated Fatty Acids
Menhaden are an excellent source of long chain n-3 polyunsaturated fatty acids 
(PUFA), specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
(Ackman et al. 1976; Morris and Culkin 1989). PUFAs are essential for nonnal growth, 
food utilization, health, and reproductive viability o f fishes (Higgs and Dong 2000). The 
fatty acid composition of fish diets strongly influences the fatty acid composition of cell 
membrane phospholipids, signal transductions, and plasma lipid levels, which in turn can 
have a profound effect on the immune system (Balfry and Higgs 2001). For example, 
high levels of dietary n-3 PUFA increased the strength o f the blood cell membrane in 
Atlantic salmon suffering from cold-water vibriosis ( Vibrio salmonicida) (Salte et al 
1988). Macrophages are a prime producer of byproducts of fatty acids (eicosanoids), 
which have a wide array o f actions modulating immune responses (Johnston 1988).
DHA, along with arachidonic acid (AA) makes up one third of brain lipid and also plays 
a key role in retinal, neural, and synaptic membranes, specifically the myelin sheath 
(Gurr et al. 2002). Marine fish lack A5 fatty acid desaturase, which converts lower fatty 
acids to PUFAs, therefore these fish must obtain PUFAs in their diet (Owen et al. 1972, 
Kanazawa et al. 1979, Higgs and Dong 2000). Studies involving varying levels of PUFA 
in feed for a variety o f aquaculture-raised fish indicated increased growth rate and 
immune resistance in feed with good sources of PUFAs (Erdal et al. 1991, Fair et al.
1993, Lie et al. 1993).
Innate Immunity and Nutrition
6Humoral innate immunity involves a variety of substances in the serum, mucus, and 
eggs that nonspecifically inhibit growth of microorganisms. These antimicrobial 
substances include lysozyme, complement, interferon, C-reactive protein, transferrin, 
lectin, and many others (Yano 1996). Many studies have demonstrated the importance of 
micronutrients such as vitamins C and E in disease resistance. Vitamin C in the form of 
ascorbic acid is a necessary factor in steroid synthesis, helps maintain activity of 
glutathione peroxidase and superperoxide dismutase, and because of its role in collagen 
synthesis is essential for normal wound healing (Halver 1972, Halver 1989, Sato et al. 
1978). Vitamin C has also been shown to be important in complement activity. Many 
groups have demonstrated a positive relationship between ascorbic acid and complement 
level, in a variety o f fishes (Lin and Shiau 2005, Ai et al. 2004, Ortuno et al. 1999, and Li 
and Lovell 1985). In a study by Li and Lovell (1985) channel catfish fed the diet with 
ascorbic acid had higher complement activity and phagocytic activity. In addition, when 
experimentally infected with Edw’arsiella ictaluri fish fed the diet without ascorbic acid 
showed 100% mortality and fish fed 300 mg/kg and 3000 mg/kg showed 15% and 0% 
mortality respectively. Similar studies with Vitamin E added to the diet have shown 
increased complement activity, lysozyme, and reduced mortality when challenged with 
bacteria (Wang et al. 2006, Lin and Shiau 2005).
Macronutrients also play an important role in the humoral innate immune system of 
fishes. Many groups have evaluated lipid supplementation, in the form of n-3 
polyunsaturated fatty acids (PUFAs) (Blazer et al. 1989; Sheldon and Blazer 1991, Erdal 
et al. 1991, Kiron et al. 1995). Menhaden oil is a commonly used supplement because o f 
its high level of PUFAs. Several studies report a significant increase in macrophage
7bacterial killing activity and antibody titers in fish fed diets high in n-3 PUFAs or 
menhaden oil (Blazer et al. 1989, Sheldon and Blazer 1991, Erdal et al. 1991; Kiron et al.
1995). In addition Kiron et al. (1995) found lower mortality rates (10-15%) in rainbow 
trout hatchlings challenged with IHN virus when fed diets high in n-3 PUFAs compared 
to diets high in n - 6  PUFAs. The recent depletion of Chesapeake Bay menhaden stocks 
(Uphoff 2003), and thus a reduced contribution to striped bass diet, may affect their 
growth, nutritional intake, and immune function.
Diet and HDL/ApoA-I Production
High-density lipoprotein (HDL) is a small, dense association of lipids containing a 
cholesterol ester core surrounded by a phospholipid monolayer. HDL is produced in the 
liver as a nascent particle consisting o f a phospholipid monolayer without a lipid core. 
Apolipoprotein A-I (ApoA-I) readily associates with the HDL particle and activates the 
enzyme lecithinxholesterol acyl transferase (LCAT) which catalyzes the conversion of 
triglycerides on the surface of HDL into cholesterol esters, which are incorporated into 
the core o f the HDL particle. In humans and other mammals, ingested levels o f dietary 
fat, especially polyunsaturated fats, modulate levels of HDL and ApoA-I secretion 
(Velez-Carrasco et al. 1999, Calleja et al. 2000, Shige et al. 2000, Wang et al. 2001, Rong 
et al. 2002, Hatahet et al. 2003). Cultured intestinal cells secrete ApoA-I into the cell 
media when incubated with linoleic acid (n-3 PUFA) (Rong et al. 2002). In addition, a 
diet high in n-3 PUFAs stimulated production of hepatic ApoA-I mRNA and plasma 
ApoA-I in rats (Calleja et al. 2000). Patients with chronic renal failure experienced an 
8 % increase in HDL levels after eating a diet with 2.4g o f n-3 PUFAs per day for eight 
weeks (Svensson et al. 2004). Studies in fishes suggest the importance o f a diet high in
n-3 PUFAs for growth and immune health. Fish diets are often supplemented with 
menhaden oil (Fair et al., 1993, Lingenfelser et al. 1995, Sheldon and Blazer 1991), but 
specific changes in HDL or ApoA-I secretion have not been investigated.
Apolipoprotein A-I
ApoA-I is an alpha-helical, amphipathic protein which comprises approximately 70% 
of total HDL associated proteins in humans and salmonids (Babin and Vernier 1989, 
Brouillette et al. 2001). ApoA-I is synthesized in the liver as a preprolipoprotein cleaved 
in hepatocytes before subsequent release into the plasma as a prolipoprotein. The “pro” 
segment is cleaved by a specific protease and converted into the mature ApoA-I 
(Hospattankar et al. 1987). Two molecules of ApoA-I associate with each other in an 
antiparallel fashion, forming an elliptical-shaped dimer. Specific contacts are made, 
including the interdigitation o f side chains and salt bridges (Figure 3). The alpha helices 
are oriented in such a way as to allow a contiguous hydrophobic strip that runs along the 
length o f the protein, making it well suited for binding lipids. In the absence o f lipids, 
two dimers can bind to fonn a tetramer (Brouillette et al. 2001).
ApoA-I has a variety of functions; however the primary role is reverse cholesterol 
transport. ApoA-I is the most potent activator o f LCAT, which catalyzes the esterification 
o f cholesterol. This results in a more soluble cholesterol-HDL complex, which increases 
the cholesterol transport capacity of the HDL particle for subsequent removal by the 
liver. In addition, ApoA-I mediates cholesterol efflux from cells to HDL (Oram & 
Yokoyama 1996).
ApoA-I expression has not been fully investigated in fishes, however ApoA-I 
mRNA has been found in epidermal cells and liver of carp (Concha et al. 2003). Other
9studies have discovered many sites of synthesis of ApoA-I in mammals (Elshourbagy et 
al. 1985, Haddad et al. 1986, Lenich et al. 1988) such as skeletal muscle, liver, intestine, 
brain, testes, and heart, however the main sites of synthesis are liver and intestine. It is 
possible there could be many different sites of synthesis o f ApoA-I in fishes. 
Antimicrobial Action and Mechanisms of Apolipoprotein A-I
ApoA-I has a variety of immune-related properties including inhibition of bacterial 
endotoxin, antiviral activity, and inhibition of inflammatory cytokines (Yokoyama et al. 
1980, Ulevitch et al. 1981, Munford et al. 1981 and 1985, Srinivas et al. 1990, Cockerill 
et al. 1995). Mammalian ApoA-I also demonstrates direct antimicrobial activity against a 
variety of viruses and bacteria (Tada et al. 1993).
Human ApoA-I also has antiviral activity against Herpes simplex virus (HSV),
Human immunodeficiency virus (HIV), and xenotropic murine virus (Srinivas et al 1990, 
1991, Alonso-Villaverde et al. 2003, Kane et al. 1979). HSV and HIV entry into host 
cells involves fusion o f the viral membrane with the host cell membrane. ApoA-I and 
amphipathic synthetic peptide analogs inhibit both virus-induced cell fusion and 
penetration o f HSV and HIV (Srinivas et al. 1990 and 1991, Owens 1990). The focus o f 
our study is the antibacterial action of ApoA-I.
Recent studies involving ApoA-I have been conducted on non-mammalian 
vertebrates. ApoA-I isolated from carp (Cyprinus carpio) demonstrated in vitro 
antibacterial activity (Concha et al. 2004). ApoA-I was co-incubated with Escherichia 
coli, Yersinia ruckeri, or Pseudomonas sp. The EC5 0 S observed after 24 hours were 5.2, 
2.6, and 2.6 pM respectively. ApoA-I has also been isolated from cod, rainbow trout, sea 
bream, skate, brown bullhead, and sea turtle (Manadottir and Lange 2004, Duggan et al.
1 0
2001, Denslow et al. 1994, Duggan and Callard 2001). However Concha et al. (2004) 
were the first to demonstrate the antimicrobial activity o f ApoA-I and implicate it as a 
protein possibly involved in innate immunity in fish.
The actual mechanism of antimicrobial activity by ApoA-I has not yet been 
identified; however, several mechanisms have been suggested. One hypothesis is that the 
high affinity o f ApoA-I for cholesterol and lipids allows it to remove cholesterol from a 
cell, which could affect a pathogen’s membrane integrity. In addition, bacterial growth 
may be inhibited by the insertion o f lipids or proteins into the cell membrane (Tada et al. 
1993). Synthetic amphipathic (-helical model peptides can form ion channels in 
phospholipid bilayers of both Gram-positive and Gram-negative bacteria (Agawa et al.
1991). Thus the inherent structure o f the ApoA-I protein may confer its antimicrobial 
activity.
Apolipoprotein A-I and Inflammation
ApoA-I inhibits excessive inflammatory responses involved in diseases such as 
rheumatoid arthritis, atherosclerosis, and lupus. Both HDL and ApoA-I bind and 
inactivate lipopolysaccharides (LPS) or endotoxin secreted from gram-negative bacteria 
(Munford et al. 1981; Cavaillon et al. 1990; Emancipator et al. 1992; Flegel et al. 1993; 
Massamiri et al. 1997). LPS initiates inflammatory reactions, which can lead to 
endotoxic shock. LPS-binding protein transfers LPS to ApoA-I, which partially prevents 
both acute and chronic inflammatory reactions (Burger and Dayer 2002).
BLANK PAGE 
INFORMATION MISSING
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GOALS AND OBJECTIVES
The goals of these studies were first to isolate and identify ApoA-I in striped bass 
and show that it exhibits the antibacterial activity seen in mammals and carp. The second 
goal of these studies was to determine if  a diet with or without menhaden oil could 
regulate production of ApoA-I in the blood o f striped bass. In order to achieve these 
goals, experiments were designed to address the following objectives:
1. Purify ApoA-I from striped bass plasma using Affi-Gel Blue gel affinity 
chromatography, delipidation, and molecular weight fractionation.
2. Amplify ApoA-I gene from striped bass genomic DNA using degenerate 
primers and sequence the DNA.
3. Use 5’ and 3 ’ RACE to obtain the entire coding region of the ApoA-I gene 
from cDNA.
4. Obtain N-terminal amino acid sequence of striped bass ApoA-I.
5. Perform antibacterial assays with purified ApoA-I and E.coli, Streptococcus 
sp., and Mycobacterium marinum.
6 . Perform a diet study with juvenile striped bass fed diets supplemented with 
either 0% menhaden oil or 8 % menhaden oil to evaluate regulation o f ApoA-I 
in response to high-fat diet.
7. Use a specific striped bass monoclonal antibody to quantify ApoA-I in striped 
bass serum samples from the diet study.
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MATERIALS AND METHODS
Sample Collection.
Striped bass blood samples were collected from wild-caught fish from the 
Chesapeake Bay, VA, as part of the Chesapeake Bay Multi-species Monitoring and 
Assessment Program (ChesMMAP). In addition, blood samples were collected from 
wild-caught fish in the York River, VA (Virginia Marine Resources permit # 05-76 and 
VIMS IACUC # 2005-0706-1). Blood was collected from the caudal vein using a sterile 
needle and syringe and put in sterile 4 mL vacutainers containing EDTA (Becton 
Dickinson, Franklin Lakes NJ). Samples were kept on ice and transported to the lab 
where they were centrifuged at 2000 x g  to separate plasma from blood cells. Plasma 
was frozen at -80°C until use.
ApoA-1 purification, characterization and detection
Studies involving purification, characterization and determining antimicrobial 
properties of ApoA-I were performed on 2005 archival plasma samples obtained during 
ChesMMAP surveys, as well as additional samples collected from wild striped bass in the 
Chesapeake Bay. HDL containing ApoA-I was purified from plasma using affi-gel blue 
gel affinity chromatography (Concha et al. 2004). Affi-gel blue affinity gel (BioRad, 
Hercules CA) is a beaded, crosslinked agarose gel with covalently attached Cibacron 
Blue F3GA dye. The blue dye functions as an ionic, hydrophobic, aromatic or sterically 
active binding site in various applications. The plasma samples were first dialyzed 
against equilibration buffer (50 mM sodium citrate, 50 mM sodium chloride, pH 6.5).
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After the plasma was applied to the column, the column was washed with 50 mL of wash 
1 buffer (50 mM sodium citrate, 350 mM sodium chloride, pH 6.5) to remove bound 
albumin. The column was then washed with 50 mL of wash 2 buffer (50 mM sodium 
citrate, 50 mM sodium chloride, 300 mM sodium thiocyanate, pH 6.5) to further desorb 
albumin. HDL was selectively eluted by 5mL stepwise washes with 
anilinonapthalenesulfonate (ANS) buffer (50 mM sodium citrate, 50 mM sodium 
chloride, 2 mM ANS pH 6.5). The fractions were electrophoresed on SDS-PAGE gels 
and stained with ProteoSilver Silver stain (Sigma, St. Louis MO) or Sypro Ruby total 
protein stain (Invitrogen Corp., Carlsbad CA). Fractions containing a protein at 25kD 
with little or no contaminating proteins were pooled.
ApoA-I was separated from HDL-lipids by ethanol-ether delipidation (Scanu and 
Edelstein 1971) for use in antimicrobial assays. The pooled HDL from the Affigel blue 
column was first dialyzed in 150 mM sodium chloride, 1 mM EDTA pH 7.0 and 
concentrated using 15 mL centrifugal concentrators (Millipore, Billerica MA or Pierce, 
Rockford, IL). Approximately 2 mL of the samples was then mixed with 50 mL of 3:2 
ethanokethyl ether and kept at -20°C for four to six hours. The precipitate was then 
centrifuged at 2000 x g  for 15 min to pellet precipitated protein. The protein pellet was 
suspended in 50 mL of ice-cold ether and stored overnight at -20°C to remove any 
remaining lipids. The suspension was centrifuged to pellet precipitated proteins and 
dried under a stream of nitrogen.
Total lipid extractions were performed on striped bass serum, delipidated serum 
samples, and lipid soluble fractions to determine the efficacy of the delipidation protocol. 
The serum sample was mixed with chlorform:methanol:serum (2:2:1 by volume)
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according to Folch (1957). A two-phase system was created in which the upper phase 
(aqueous) contained polar components. The lower phase (chloroform containing lipids) 
was removed and dried under a stream of nitrogen. The lipid soluble fractions 
(solubilized in 4:1 ether:ethanol) and the delipidated proteins were also dried under 
nitrogen. Lipids were then re-suspended in 1ml of 1:1 chloroform:methanol. Next each 
sample was transesterified with boron trifluoride (BF3) and hexane and heated for 15 min 
at 100°C(Metcalfe and Schmitz 1961). Samples were extracted with carbon disulfide, 
and the organic phase was dried under nitrogen and re-suspended in hexane (Marty et al.
1992). The BF3 attaches a methyl group to each fatty acid and then the fatty acid methyl 
esters (FAMEs) were analyzed according to Chu and Ozkizilcik (1995) using gas/liquid 
chromatography and identified by comparing their retention times with a C23 standard 
(Sigma, St. Louis MO).
For the final purification, delipidated ApoA-I pellets were dissolved in 50 mM 
tris-buffered saline with 1 mM EDTA (pH 7.5) (TBSE) and then applied to an XK 1.6 x 
70cm column (Amersham, Piscataway NJ) with S-300 Sephacryl media (Amersham, 
Piscataway NJ) using the buffer listed above. Fractions were collected using a fraction 
collector model 2110 (BioRad, Hercules CA) and electrophoresed on SDS-PAGE gels. 
They were then stained with ProteoSilver Silver stain (Sigma, St. Louis MO), 
Coommassie blue stain (Sigma, St. Louis MO), or Sypro Ruby total protein stain 
(Invitrogen Corp., Carlsbad CA) to determine which fractions contained a 25kD band 
with as few other contaminants as possible. These fractions were pooled and dialyzed in 
ImM sodium citrate, pH 6.5. The protein concentration was analyzed via Bradford
16
method (BioRad, Hercules CA) or bicinchoninic acid (BCA) method for protein 
quantification before use in antibacterial assays.
Development of Primers.
Degenerate primers were derived from consensus teleost ApoA-I sequences 
(Fundulus heteroclitus (AAU50536), Pseudopleuronectes americanus (AAT01918), 
Gadus morhua (AAU87042), Sparus aurata (AAC78689), Salmo salar (CAA36942), 
and Cyprinus carpio (CAC34942)) from GenBank following ClustalW alignment 
(Thompson, 1997). The forward primer (29F) used was
5 ’ - ATGCARGCNGAYGCNCCNTCNCARYTNGMNCA- 3 ’ and the reverse primer 
(222R) used was 5 ’ -NADYTGNTC YTTRTAYTCYTCNRGRTANGG-3 ’ (Invitrogen 
Corporation, Carlsbad CA).
Amplification of striped bass ApoA-I gene segment using PCR
PCR reactions contained final concentrations of 2.5 U o f Platinum Taq DNA 
polymerase High Fidelity, 0.5 mM dNTPs, 3.5 mM MgC12, lx  PCR Buffer (Invitrogen, 
Carlsbad, CA), 4 pM for each primer, and 1 pi (25ng) genomic striped bass DNA in a 
final volume of 50 pi. The genomic striped bass DNA was a gift from Dr. David 
Gauthier and was extracted from striped bass spleen using a Qiagen Dneasy kit. PCR 
parameters consisted of an initial denaturation of 2 min at 94°C, 2 cycles o f 2 min 
denaturation at 94°C, 2 min annealing at 30°C, and 3-5 min extension at 72°C; 35 cycles 
o f 2 min denaturation at 94°C, 2 min annealing at 55°C, and 3-5 min extention at 72°C, 
followed by a final extension for 10 min at 72°C. All PCR amplifications were 
performed on MJ Research, Inc. thermocyclers model PTC-200 (Watertown, MA). PCR 
products were electrophoresed on a 1 % agarose gel, stained with ethidium bromide and
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visualized using an ultraviolet-light transiluminator (Alpha Innotech Corp., San Leandro 
CA) to visualize bands for excision. Individual bands were excised from the gel and 
DNA extracted using QIAquick gel extraction kit (Qiagen, Inc., Valencia, CA). Prior to 
cloning A’s were added to PCR products after gel extraction using a protocol from 
Applied Biosystems. The reaction used 10 pi of PCR product 1.5 pi lOx buffer 1 without 
MgCL, 0.2 pi Taq polymerase, 0.3 pi dATPs, 2.55 pi water, and 0.45 pi 50mM MgCL 
and was run at 72°C for 8-10 minutes.
Cloning.
Excised PCR fragments were cloned and transformed into OneShot TOP 10 
chemically competent E. coli, following manufacturers protocol (Invitrogen, Carlsbad, 
CA). Colonies were restreaked onto fresh agar-ampicillin plates and allowed to grow at 
37°C for 8  hours. Restreaked colonies were picked with a toothpick, added to 70 pi of 
sterile water, and boiled for 5 min at 100°C. Insert amplification was performed using 
M l3 forward and reverse primers(Invitrogen, Carlsbad CA). Reactions contained final 
concentrations of: 0.625 U of Taq DNA polymerase, 0.2 nM dNTPs, 1.5 mM MgC12, lx  
PCR Buffer (Invitrogen, Carlsbad, CA), 25 pM for each primer, and 1 pi from the boil 
prep in a final volume o f 25 pi. The parameters consisted of an initial denaturation of 2 
min at 94°C, followed by 30 cycles of lm in at 94°C, lm in at 54°C, and 1.5min at 72°C 
followed by a additional extension step at 72°C for 4 min. M l3 amps were run on 2% 
agarose gels and colonies with an approximate 800 bp insert were chosen for sequencing. 
PCR products were purified using EXOSAP (USB Scientific, Cleveland OH). In 
addition, colonies were added to YT broth and grown overnight at 37°C. Plasmid DNA
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was isolated from the bacteria using the Qiaprep Spin miniprep kit (Qiagen, Inc., 
Valencia, CA).
Sequencing and Sequence Analysis.
Samples were sequenced using BigDye Terminater v 3 . 1  Cycle Sequencing 
Reagents (Applied Biosystems, Warrington, UK) with minor modifications of the 
manufacturer’s recommendations. Sequencing reactions were composed of 10-50 ng 
template DNA, 0.32 pi M13F or M13R primer (10 pM), 0.25 pi BigDye master mix, 
0.875 pi 5x reaction mix and sterile milli-Q water to a final volume o f 5 pi. Cycle 
sequencing conditions consisted of an initial denaturation of 1 min at 96°C, followed by 
25 cycles o f 10 s at 96°C, 5 s at 50°C, and 4 min at 60°C. Amplification products were 
electrophoresed using an ABI 3130 DNA sequencer equipped with an 80 cm capillary 
loaded with POP4 gel matrix. Results were analyzed using Sequencing Analysis v.5.1.1 
software (Applied Biosystems, Warrington, UK). The resulting sequence was compared 
to those deposited in GenBank using BLAST (Altschul et al. 1990) searches of the NCBI 
database. Alignments were generated with these sequences using the ClustalW algorithm 
(Thompson, 1997) in MacVector 8.0 (Accelrys Inc., San Diego, CA) with default 
parameters.
RNA extraction
RNA was extracted from striped bass liver and reverse transcribed to cDNA. One 
striped bass was euthanized by an overdose o f MS-222 and then the liver was dissected 
using sterile techniques. Pieces of liver (approximately 60 mg each) were snap frozen in 
liquid nitrogen and RNA was extracted using an RNeasy RNA extraction kit according to 
manufacturers protocol (Qiagen, Valencia CA). RNA quality and concentration were
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determined by UV spectrophotometry at 260/280 nm, with background correction for 
protein contamination at 320 nm.
RNA-ligase mediated rapid amplification of cDNA ends (RLM-RACE)
Using the GeneRacer kit (Invitrogen, Carlsbad, CA) reverse transcription of 1 pg 
RNA was accomplished with Superscript III reverse transcriptase and GeneRacer RNA 
oligo according to the manufacturer’s protocol.
All gene specific primers (GSP) used are listed in Table 1. The primers were 
designed from the sequence of an initial 750 bp putative striped bass ApoA-I sequence 
fragment obtained using degenerate primers 29F and 222R and genomic DNA. Primer 
20F was used in combination with the GeneRacer 3 ’ primer to obtain the 3 ’ segment and 
28R was used in combination with the GeneRacer 5’ primer to obtain the 5’ segment. In 
both sets o f reactions 1 pi of cDNA was added to a mastermix containing; 0.6 pM of 
appropriate GeneRacer primer, 0.2 pM GSP 20F or 28R, and 45 pi Platinum PCR 
SuperMix High Fidelity (Invitrogen, Carlsbad, CA). Cycling parameters consisted of a 
touchdown, hotstart PCR using the following conditions: 94°C for 2 min; 94°C for 0.5 
min and 72°C for lmin, for 5 cycles; 94°C for 0.5 min and 70°C for 1 min, for 5 cycles; 
94°C for 0.5 min, 60°C for 0.5 min, and 6 8 °C for 1.5 min, for 25 cycles; 6 8 °C for 10 
min. PCR products were electrophoresed on a 2% agarose gel and appropriate sized 
bands were excised. PCR products were extracted from the gel using SNAP columns 
according to manufacturer’s protocol (Invitrogen, Carlsbad, CA). A ’s addition, cloning, 
and sequencing were performed as described previously.
2 0
2D Electrophoresis and N-terminal Sequencing
ApoA-I was separated by two-dimensional electrophoresis (2DE) using an 
Invitrogen IPG Zoom Runner System according to manufacturer’s instructions. Striped 
bass plasma (30 mg) was subjected to isoelectric focusing (first dimension) on pH 3-10 
IPG strips (Invitrogen, Carlsbad, CA.) IPG strips were electrophoresed on NuPAGE 4- 
12% gradient Bis-Tris Zoom gels (Invitrogen, Carlsbad, CA.). Proteins were transferred 
to Immobilon-FL (Millipore) and stained with Coomassie Blue R250 (BioRad). The spot 
corresponding to ApoA-I and recognized by the monoclonal antibody 6 D 6  against striped 
bass ApoA-I (supplied by Dr. Erin Bromage, VIMS) was sent to the Microchemical 
Facility at Emory University, in Atlanta, GA for N-terminal sequencing via Edman 
degradation.
Monoclonal Antibody Production
Monoclonal antibody production was performed by Dr. Erin Bromage (VIMS) 
according to previously published procedures (Bromage 2004). A brief description of the 
methods used for specific antibody production against striped bass ApoA-I are listed 
below.
Six week-old female Balb/c mice were utilised for the production of monoclones 
against APOA1. The mice (3) were intraperitoneally (IP) immunized with an oil-in- 
water emulsion of striped bass HDL purified using Affi-gel Blue (50 pg) and Freunds 
complete adjuvant (FCA), followed by booster injections at week 8  and week 1 2  of 
delipidated ApoA-I (5 pg) in Fruends incomplete adjuvant (FIA). At regular intervals, 50 
pi of blood was collected from the tail vein of immunised mice so that titres could be 
monitored during the vaccination process, and specificity monitored via Western blotting.
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Four days before the fusion (week 16) the mouse with the highest titre was injected 
intravenously (IV) with 10 pg of delipidated ApoA-1. The fusion technique used was 
derived from the methods o f Zola (Zola 2000) and Harlow and Lane (1988).
Following fusion the process of limiting dilution was conducted to ensure single 
cell cloning of hybridomas. This was performed by resuspending cells in RPMI 
supplemented with 20% NCS, to a cell density of 20 cells/ml. A 96 well tissue culture 
plate (Coming) was divided into 4 groups containing 3 columns each. To the first group 
200 pi of this solution was added, 100 pi to the second, and 50 pi and 25 pi to the final 2 
groups. Each group was then filled to 200 pi total with growth medium containing 20% 
NCS. This process ensured that 4, 2, 1 and 0.5 cells were present in the respective groups 
1 through 4. The cells were allowed to grow for 10 days before being screened by 
enzyme-linked immunosorbent assay (ELISA). Cell supemate was screened against 
purified HDL and delipidated, molecular weight fractioned ApoA-I. Wells testing 
positive for specific antibody were examined via a microscope, and those thought to 
contain a single colony were re-cloned, following the above procedure. Cloning was 
considered complete when 100% of the wells containing cells tested positive in ELISA.
In addition to ELISA, western blots were performed to ensure immunoreactivity against a 
single 25kD band believed to be ApoA-I.
ApoA-I Quantification
ApoA-I quantification in striped bass serum was performed by Western blot using 
the monoclonal antibody 6D6 (prepared by Dr. Erin Bromage, VIMS). Samples for SDS- 
PAGE were prepared using a modified version of the Laemmli protocol (Nature, 1970). 
Briefly, plasma samples were diluted in SDS reducing sample buffer (with 2-
2 2
mercaptoethanol) and boiled for 3 min. On each gel, four striped bass purified ApoAl 
standards (100 ng, 200 ng, 300 ng, and 500 ng) were loaded along with equal volumes of 
each sample (approximately 0.1 ptl o f plasma in 5ul of sample buffer) in duplicate on 15 
well 10-20% gradient Tris-HCl gels (BioRad, Hercules CA) and electrophoresed at 175V 
for lh  (BioRad protean III system). Serum proteins were transferred to Immobilon-FL 
(Millipore, Bedford, MA) in tris-glycine transfer buffer with 20% methanol for 1 h at 
100V (200-400 mA). After transfer the membranes were incubated for 1 h in 0.5% 
casein in tris-buffered saline (TBS) pH 8.0. The 6D6 antibody was diluted 1:1000 in 
0.5% casein-TBS and incubated at room temperature for 1 hour. The blot was then 
washed three times for ten min in TBS + 0.1% Tween 20 (TTBS) and incubated in goat 
anti-mouseIR 700 (Molecular Probes) secondary antibody diluted in 0.5% casein-TBS for 
1 hour in the dark. The blot was then washed three times in TTBS and visualized using 
the Li-cor Odyssey infrared imaging system (Lincoln, NE) and quantified 
densitometrically according to the manufacturer’s protocol.
Bacterial culture and maintenance.
Three bacterial cultures were used in antibacterial assays; Mycobacterium 
marinum, Escherichia coli, and Streptococcus sp. M. marinum was previously isolated 
from infected striped bass spleen and maintained by Dr. Howard Kator (VIMS). E. coli 
was obtained from ATCC culture # 25922. The Streptococcus sp. was isolated by Dr. 
Ron Thune, Gulf Coast Research Laboratories. E. coli was grown and maintained in 
sterile Mueller Hinton broth (Becton Dickinson) at 37°C (Concha et al. 2004), M. 
marinum was grown and maintained in Middlebrook broth (Becton Dickinson) at room 
temperature, and Streptococcus sp. was grown and maintained in brain-heart infusion
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broth (Becton Dickinson) at room temperature. Back-up cultures of all bacteria were 
kept on agar slants at 4°C and also frozen in 20% glycerol and stored at -20°C. 
Antibacterial assays
Initially, standard curves for cell concentration and growth time were generated 
using 96-well plates. Each bacterium was serially diluted five-fold across the plate from 
an optical density o f 0.1 at 590 nm to a dilution of 10’6 and allowed to grow in the dark at 
the ideal temperature and media until log phase was reached. Optical density (OD) 
readings were recorded at several intervals to establish a growth curve. Aliquots were 
enumerated by plating on agar plates to correlate corresponding optical density readings 
with cell number. This process allowed determination of characteristic growth time and 
starting concentration for subsequent antibacterial assays.
Antibacterial activity assays were performed using delipidated ApoA-1 in the 
microtiter broth dilution assay previously described (Friedrich et al. 1999). Assays were 
performed in sterile flat-bottom 96-well plates (Becton Dickinson). Purified ApoA-I was 
diluted in 0.2% bovine serum albumin to a concentration of 2 mg/ml and sterile filtered. 
Concentrations of ApoA-I ranged from 1 mg/ml to 0 mg/ml for Streptococcus and E. coli 
and 1.5 mg/ml to 0 mg/ml for M. marinum. Each concentration was tested in triplicate on 
each plate. Each well was then inoculated with 100 pi of 1 x 104 or 105 CFU/ml in 
triplicate rows in the appropriate broth (1,000 cells and 10,000 cells per well 
respectively). Two rows of control wells containing bacteria with a substitute protein 
(BSA) corresponding to ApoA-I concentrations were set up in duplicate on each plate 
(Figure 4). At time zero, OD measurements were taken using a microplate reader at 595
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nm (Molecular Devices) and then measurements were taken at selected intervals until the 
bacteria reached plateau phase.
Dietary study
Approximately 50 juvenile (phase 2) striped bass (30-60 gm) were obtained in 
November 2005 from the Edenton National Fish Hatchery (Edenton, NC), transferred to 
one 2,600 L tank containing flow-through well water at VIMS, and allowed to acclimate 
to the aquaria over a ten-day period. Rock salt was added to all tanks to approximately 
lppt when fish were disturbed and during transport in order to reduce stress effects. All 
fish were held in well water at the ambient room temperature (18-20°C). During the 
acclimation period, fish were fed to satiation the same dry pellets used at the fish 
hatchery (Zeigler Brothers). After the initial 10 day period all fish were fed the 
experimental high-fat diet for 50 days. On day 0 of the dietary study, six fish were 
sacrificed and exsanguinated for ApoA-I quantification. Remaining fish were weighed, 
measured for length, and distributed into two 2,600-liter tanks (22 fish per tank).
Fish were fed either the high-fat diet or the low-fat diet identical to those used in a 
previous study of the effects of dietary menhaden oil on growth and fatty acid 
composition o f hybrid striped bass (Fair et al. 1993). These highly defined diets were 
custom prepared by Zeigler Brothers (Gardner, PA) and varied only in the amount of 
menhaden oil added (0% menhaden oil in low-fat diet, 8% menhaden oil in high-fat diet) 
(Table 2). Fish were fed up to 2 percent o f their body weight per day for a period of four 
months.
Flow-through well water was used throughout the study and the temperature was 
maintained at 18-20 °C. This temperature range is equivalent to that found in the lower
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Chesapeake Bay from October to November when striped bass are known to be abundant 
and feeding. Fish in each group were reared in identical water conditions. Water quality 
parameters such as nitrite and ammonia were measured periodically to help maintain the 
fish in a healthy environment.
Fish were sampled on days 0 ,45, and 120. On day 0 nine six were exsanguinated 
for ApoA-I quantification and on days 45 and 120, 11 fish from each treatment were 
exsanguinated for ApoA-I quantification. Length and weight was measured before 
euthanasia for each time-point. All plasma samples were frozen at -80°C for later 
quantification of ApoA-I concentration.
Statistical Analysis
GraphPad Prism and Microsoft Excel were used for all statistical analyses. For 
detection of significant differences between time-points and diets in the diet study the 
Student’s T-test was used at an alpha value of 0.05. In order to determine significant 
bacterial growth inhibition compared to control, a One-way ANOVA followed by 
Dunnett’s multiple comparison test were used also at alpha values of 0.05.
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Figure 1
Chesapeake Bay striped bass juvenile index in Maryland and Virginia waters from 1958- 
2004. The indices are presented as Arithmetic Mean Catch per Haul. Indicated with 
arrows are the years when moratoriums on fishing o f striped bass existed in Maryland 
(1985-1990) and Virginia (1989-1990). The graph was taken from Chesapeake Bay 
Program website http://www.chesapeakebav.net/bavbio.htm.
V
A
St
ri
pe
d 
Ba
ss
 
Ju
ve
ni
le
 
In
de
x 
MD
 
St
rip
ed
 
Ba
ss
 
Ju
ve
ni
le
 
In
de
x
27
Maryland
Moratorium
24
2 2
21
* m <*§
CM <Nf________________ Virginia
Moratorium 
1 9 6 9 -  1 3 9 0
13
13
r r i T ’TTTi1
B U R
28
Figure 2
Estimated Atlantic coast menhaden population from the National Marine Fisheries 
Service population dynamics team data. This chart represents the estimated Atlantic 
Coast Menhaden population, ages 2-8. The population in 1999 is 66% below the ten year, 
historic average from 1955 to 1964.
Chart prepared by Chesapeake Bay Ecological Foundation, Inc.
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Figure 3.
ApoA-I structure when bound to HDL. Top figure shows an ApoA-I dimer binding to a 
molecule of HDL (Kumar et ah, 2002). The bottom figure shows two ApoA-I monomers 
held together with salt bridges (Segrest et al. 1999).
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Figure 4
Antibacterial assay setup design o f 96-well plate. First BSA was added to the top two 
rows as an inert protein control. Concentrations are shown in pg/ml of 0.2% BSA. Row 
A shows concentrations used in assays using E. coli and Streptococcus sp. and row B 
were concentrations used in assays using M. marinum. Purified ApoA-I was diluted in 
0.2% BSA and added to the wells using concentrations shown in row A and B. To row 1 
and rows 3-5, 100 pi o f a 105 cell/ml suspension of bacteria was added to each well. To 
row 2 and rows 6-8 100 pi of a 104 cell/ml suspension o f bacteria was added to each well. 
After incubation high turbidity or optical density was seen in wells with the darkest 
coloring.
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Table 1
List of Primers
Primer Name Sequence
29F 5'-ATGCARGCNGAYGCNCCNTCNCARYTNGMNCA-3'
2 2 2 R 5 N AD YTG NTCYTTRTA YTCYTC N RG RTA N G G - 3'
20F 5'-ATCTCGCACCCAAGCAGGTTCAG-3'
28R 5'-GAACAGACTCCACAATGGGCATCAG-3'
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Table 2
Artificial Diet Composition
Ingredient composition and proximate analysis of 
experimental diets (dry weight basis)
Ingredient 0% MO 8% MO
Grain (100% gelatinized) 20.7 16.6
Fat (lecithin) 0.5 0.5
Fish oil (menhaden) 0 8
Wheat (ground whole) 20.7 16.6
Bloodmeal (85% protein) 5 5
Fishmeal (anchovy) 28.3 28.3
Liquid fish solubles 2.5 2.5
Feathermeal (hydrolyzed) 10 10
Texturized vegetable protein 10 10
USFW # 3  minerals 0.1 0.1
Choline C l (70%) 0.1 0.1
Ascorbyl 2-polyphosphate 0.3 0.3
USFW # 3 0  vitamin premix 0.2 0.2
Ameribond 1.7 1.7
Proximate analysis (% )
Crude protein 40 .4 39.9
Crude fat 4.3 13
Crude ash 8 7.8
Moisture 8.6 7.2
Nitrogen-free extract 38 .7 32.1
Calcium 1.6 1.8
Phosphorus 1.1 1.1
Figure taken from Fair et al. 1993
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Results
ApoA-I Purification
ApoA-I was purified from striped bass serum using a three step process: Affinity 
chromatography using Affi-gel Blue (BioRad) and elution of HDL using 8- 
anilinonapthalene sulfonate (ANS) (Figure 5), ethanol: ether delipidation removing lipid 
associated proteins from HDL, and gel filtration chromatography to isolate ApoA-I from 
other HDL associated proteins including apolipoprotein A-II (Figure 6). After Affi-gel 
Blue purification and delipidation steps, GC analysis o f delipidated HDL confirmed 
removal of all lipids. Fractions from the gel filtration column were visualized on SDS- 
PAGE gels stained with ProteoSilver silver stain to identify the purest samples, which 
were subsequently pooled.
In this study, delipidated ApoA-I was used for monoclonal antibody development, 
antibacterial assays, and western blot standards. ANS has a very high affinity for ApoA-I 
(Amathauer et al. 1988) and could not be separated from ApoA-I by dialysis. Because of 
this the ApoA-I samples containing any ANS were not used for antibacterial assays. 
However, ApoA-I samples containing trace amounts o f ANS were used as ApoA-I 
western blot standards. Proteins washed off the Affi-gel Blue column before ANS 
washes (specifically wash 2) were delipidated and ApoA-I was purified using gel 
filtration chromatography. This purified ApoA-I without ANS was used in antibacterial 
assays.
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N-terminal Amino Acid Sequencing
Striped bass plasma was subjected to 2DE in order to obtain an isolated ApoA-I 
spot to be used for N-terminal amino acid sequencing. Monoclonal antibody 6D6 
recognized a single 25kD spot with a pi of approximately 5.0 (Figure 7). The protein 
spot was subsequently sent to Emory University Microchemical Facility (Atlanta, GA) 
for N-terminal sequencing via Edman degradation. The resulting sequence 5’- 
ASLQADAPSQLAHVRAAMDVYLTQ-3’ was compared to those deposited in 
GenBank using BLAST (Altschul et al. 1990) searches of the NCBI database. Results of 
the BLAST searches match other ApoA-I sequences of six other fish species with E- 
values as low as 10'7 (Table 3). In addition, the N-terminal sequence matched the 
translated ApoA-1 sequences we obtained from striped bass genomic DNA and cDNA. 
ApoA-I Sequence Analysis
An approximately 750bp fragment was amplified by PCR from genomic striped 
bass DNA using degenerate primers designed from an alignment of several teleost ApoA- 
I sequences. The amplicon was cloned and 40 clones were sequenced. The resulting 
sequence o f clone 3_1 was compared to those deposited in GenBank using BLAST 
(Altschul et al. 1990) searches of the NCBI database. Results o f the BLAST searches 
indicated a match to other ApoA-I fish sequences with E-values as low as 10'19 (Table 4). 
When the translated amino acid sequence of clone 3_1 was aligned to other ApoA-I 
sequences a possible 179 bp intron was found. The sequence contains the universally 
conserved nucleotides 5’-GT and the 3’-AG indicating splice sites as well as a 
pyrimidine-rich region upstream from the 3 ’ end, consistent with introns in higher 
organisms (Lodish et al. 1995)(Figure 8). When the intron was removed from the
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sequence it aligned with other intronless fish ApoA-I sequences. Additional data that 
helped to confirm the identity o f the isolated clone was the match between the last 10 
amino acids of the N-terminal sequence data and the first 10 amino acids of the putative 
amino acid sequence of clone 3_1 translated from the DNA sequence (Figure 9).
In addition to cloned segment 3 1, 5’ and 3’ RACE was performed to obtain
sequence information of the 5’ and 3’ ends of the striped bass ApoA-I gene. A 537 bp 
segment was sequenced using primer 28R and the GeneRacer 5’ primer. The DNA 
sequence of this segment when translated aligns exactly with the N-terminal sequence of 
the protein and with the translated DNA sequence of clone 3_1. In addition, a 858 bp 
segment was sequenced using primer 20F and the GeneRacer 3’ primer. Primers 20F and 
28R were designed to produce overlapping sequences (130 bp) and the resulting 5’ and 3’ 
sequences do overlap in the 400 bp region. In addition the 5’ and 3’ sequenced segments 
aligned with the previous sequence o f clone 3_1. (Figure 10) When 5’ and 3’ sequences 
were combined and translated the resultant amino acid sequence was 275 amino acids 
long.
The various characteristics of different segments of the human ApoA-I nucleotide 
and amino acid sequences were discussed by Shoulders et al. (1983). When the striped 
bass ApoA-I amino acid was aligned to human ApoA-I, regions previously characterized 
in the human sequence can be identified in the striped bass sequence. First the human 
ApoA-I gene contains an intron at the same point in the sequence as striped bass ApoA-I 
does. Second, the pre and pro segments of human Apo A-I are highly conserved at the 
sequence level in striped bass ApoA-I. Finally, the different helices have been identified
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in human Apo A-I (Brouillette et al. 2001) and those corresponding regions have been 
highlighted in the striped bass amino acid sequence (Figure 10).
ApoA-I is modestly conserved among species, both at the level of the nucleotide 
and amino acid sequence, however there are features that are quite conserved such as its 
all a-helical secondary structure, predominantly amphipathic in nature and characterized 
by the presence of several 22 and 11-residue amphipathic a-helices punctuated by proline 
residues (Koppaka 2001). Using the PHDsec program
(http://cubic.bioc.columbia.edu/predictprotein) a prediction of 95.6% of a-helical content 
for the combined sequence of 5’ and 3’ segments was obtained. The sequence also 
contains several conserved repeats and proline residues close to the carboxy-terminal end 
of the protein consistent with other ApoA-I sequences.
Antibacterial Assays
An inhibition in growth up to approximately 80% compared to control was seen 
in E. coli incubated with 500.0-1000.0 p,g/ml ApoA-I for assay 2. The observed growth 
inhibition was seen after 5.5 hours o f incubation at 37°C (as shown in assay 1). 
Concentrations o f 750.0 and 1000.0 p,g/ml completely inhibited growth of E. coli in assay 
2. Inhibition of growth (at least 20%) was seen at concentrations of approximately 3.9 
[ig/ml using a starting concentration of 5x10 cells/ml and 31.3 ^ig/ml using a starting
concentration of 5x104 cells/ml for assay 2 (Figure 12).
There was also significant reduction in growth (One-way ANOVA, Dunnetts 
multiple comparison) compared to control seen in Streptococcus sp. incubated with
3greater than 250.0 pg/ml ApoA-I (Figure 13). At both starting concentrations (5x10
40
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and 5x10 cells/ml) o f Streptococcus sp. there was no observed growth (100% inhibited) 
at concentrations higher than 500 pg/ml (Figure 14).
M. marinum was more sensitive to ApoA-I than either E. coli or Streptococcus sp. 
There was significant reduction in M. marinum growth compared to control (80-100% 
inhibition) at concentrations higher than 125.0 pg/ml and at concentrations higher than 
375.0 pg/ml there was no significant growth compared to control (One-way ANOVA, 
Dunnetts multiple comparison) (Figure 14). Growth inhibition was seen after 12 hours 
of incubation at room temperature. In addition, there was significant stimulation of M. 
marinum growth compared to control at low levels of ApoA-I for all time points 
measured (15.6, 31.3, and 62.5 pg/ml for assay 1; 62.5, 125.0, and 250.0 ^ig/ml for assay 
2) (Figure 15). Less relative growth inhibition was seen in all assays with starting 
concentrations o f 5x104 cells/ml versus 5x103 cells/ml, however similar trends were seen 
in assays with the higher starting concentration of bacteria. For simplicity, data from 
assays using starting concentrations of 10 cells/ml are shown in figures.
Regulation o f  Apo A-I levels by diet
Two groups o f 22 juvenile striped bass were fed a diet varying in menhaden oil 
(MO) (0% MO = low fat; 8% MO = high fat) (Fair et al. 1993) to determine if a diet 
varying in lipid content altered levels o f  ApoA-I in striped bass plasma. There was no 
significant difference in Apo A-I concentration over time (One-way ANOVA) or between 
the high fat and low fat groups (Student’s T-test) (Figure 16). There was no significant 
difference (Student’s T-test) in weight between the two groups at any time point (Figure 
17) even though the high-fat group ate slightly more on average than the low-fat group 
(1.5 ± 0.5 % BW/day, 1.0 ± 0.4% BW/day respectively).
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There was no significant relationship between diet and ApoA-I levels found in 
this diet study. However, plasma samples o f wild striped bass do show significant 
variation in Apo A-I levels (Figure 18). Random samples of striped bass plasma were 
selected from ChesMMAP archives (2005) and screened for ApoA-I. Concentrations 
ranged from 1 mg/ml up to greater than the highest ApoA-I standard of 5 mg/ml. 
Differences greater than 10-fold were found between samples (Figure 20). We have not 
identified a relationship between high levels o f Apo A-I and diet in the wild striped bass 
samples, however this figure shows that there can be a wide variation in plasma ApoA-I 
levels.
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Figure 5
SDS-PAGE of striped bass plasma proteins eluted from Affi-gel Blue column.
Lane 1 (Wash 1); Lane 2 (Wash 2); Lane 3 (anilinonapthalenesulfonate (ANS) wash). 
Wash 1 contains all proteins not bound to the gel matrix. Wash 2 elutes albumin as well 
as some HDL molecules. The ANS wash selectively elutes HDL molecules containing 
Apo A-I as well as other HDL associated proteins. Approximately 4 p,g of total protein 
from each wash was electrophoresed on a gradient SDS-PAGE gel (4-12%) stained with 
Sypro Ruby total protein stain (Invitrogen Corp., Carlsbad CA).
4 43
75kD
25kD
1 2 3
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Figure 6
Gel filtration o f delipidated wash 2 fraction obtained from the Affi-gel Blue column 
(Figure 1). Five pg of fractions containing ^ 0.1 mg/ml o f total protein were 
electrophoresed by SDS-PAGE and visualized with Coomassie blue stain. ApoA-I 
enriched fractions were pooled for antibacterial assays and for western blot quantification 
standards.
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Figure 7
Two-dimensional electrophoresis of striped bass plasma using the Zoom-IPG system 
(Invitrogen Corp., Carlsbad CA). . Plasma was electrophoresed on an IPG strip (pH 3-10) 
followed by 4-12% SDS-PAGE. A) 30 p,g of striped bass plasma stained with 
Proteosilver silver stain (Sigma-Aldrich Co., St. Louis MO). B) Protein spot recognized 
using monoclonal antibody 6D6. The protein corresponding to this spot was 
subsequently used for N-terminal amino acid sequencing.
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Figure 8
Full 734 bp nucleotide sequence o f clone 3_1 including the intron and aligned amino acid 
sequence shown in two open reading frames. Splice sites for the intron are boxed in and 
the intron is highlighted in dark grey. In light grey the amino acid sequence begins in 
open reading frame B and then continues after the intron in open reading frame C.
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S e q u e n c e  R an ge: 1 t o  734
10 20  30 40 50 60 70
CGTCCGGGCCGCTATGGATGTGTACCTGACTCAGGTGAAGGACAGTGCCAACAAAGCCCTCGACCAGCTC 
GCAGGCCCGGCGATACCTACACATGGACTGAGTCCACTTCCTGTCACGGTTGTTTCGGGAGCTGGTCGAG 
V R A A M D V Y L T Q V K D S A N K A L D Q L>
________TRANSLATION OF 50_1_F_E D IT  [B ]___________________   >
S G P L W M C T * L R * R T V P T K P S T S S >  
________________________TRANSLATION OF 50 1 F EDIT [C ]___________________________>
80 90 100  110 120  130  140
GATGATACTGAGTACAAGGAGCTTAAGTAAGGCCTCATTATTCACCTTAGTCAGTCTCACTTTCTGTAAT
CTACTATGACTCATGTTCCTCGAAT' CAijTTCCGGAGTAATAAGTGGAATCAGTCAGAGTGAAAGACATTA 
D D T  E Y K E L K * G L I  I  H L S Q S H F L *>  
____________________TRANSLATION OF 50 1 F EDIT [B ]____________________________ >
M I L S T R S L S K A S L F T L V S L T F C  N> 
 TRANSLATION OF 50 1 F EDIT [C ]____________________________ >
150  160  170  180 190  2 0 0  210
TGATGCTTGCTCCATCACTGGTTCATTTACCTTTCTTCCATTTTTTACAGTTCTCTAGTCACTATTTAGT 
ACTACGAACGAGGTAGTGACCAAGTAAATGGAAAGAAGGTAAAAAATGTCAAGAGATCAGTGATAAATCA 
L M L A P S L V H L P F F H F L Q F S S H Y L V >
_TRANSLATION OF 50_1_F_E D IT  [B ]____________________________________________________ >
* C L L H H W F I Y L S S I F Y S S L V T I * >  
_TRANSLATION OF 50 1 F EDIT [C ]____________________________________________________ >
2 2 0  230  2 4 0  250  26 0  27 0  280
CACTGCTGTGTTTATTTAACTTAAGCTAAAATGGTTTCGCTCCTCCATCTCTGTTTGCTCCCAG GGCCAC 
GTGACGACACAAATAAATTGAATTCGATTTTAGCAAAGCGAGGAGGTAGAGACAAACGAGGC •TCCCGGTG 
T A V F I  * L K L K W F R S  S I  S V C S  \r  G H> 
TRANSLATION OF 50 1 F EDIT [B ]____________________________ >
S L L C L F N L S * N G F A P P S L F A P R A  T> 
 TRANSLATION OF 50_1_F_E D IT  [C ]____________________________>
2 9 0  300  310  320  330  340  350
CCTTTCTCAGCGCCTGGAGGACATGTACAATCAGGTTAAGACCCTGCAGGGTGCTGTTTCCCCCATGACC 
GGAAAGAGTCGCGGACCTCCTGTACATGTTAGTCCAATTCTGGGACGTCCCACGACAAAGGGGGTACTGG 
P F S A P G G H V Q S G * D P A G C C F P H D >
 TRANSLATION OF 50_1_F_E D IT  [B ]___________________________ >
L S Q R L E D M Y N Q V K T L Q G A V S P M T>
 TRANSLATION OF 50 1 F EDIT [C ]___________________________ >
36 0  370  3 8 0  390  400  410  420
GACAGCGTCGTCTCCACCATCTCTGATGCCACCGCTGAGTTCCGTGCCTCTGTCCTGGCTGATATTGAAG 
C T GT CGCAGCAGAGGT GGTAGAGAC TAC GGT GGC GACT CAAGGCAC GGAGACAGGAC CGAC TATAAC T T C 
R Q R R L H H L * C H R * V P C L C P G * Y *  S>
_TRANSLATION OF 50_1_F_E D IT  [B ]____________________________________________________ >
D S V V S T I  S D A T A E F R A S V L A D I  E>
_ TRANSLATION OF 50 1 F EDIT [C ]_____________________________________ >
430 440  45 0  460  470  480  490
CCCTGAAGGCTGATCTCGCACCCAAGCAGGTTCAGCTGAAGGAAGTCATCGACAAGCACATCAGTGAGTA 
GGGACTTCCGACTAGAGCGTGGGTTCGTCCAAGTCGACTTCCTTCAGTAGCTGTTCGTGTAGTCACTCAT 
P E G * S R T Q A G S A E G S H R Q A H Q * V >  
TRANSLATION OF 50  1 F EDIT [B ]____________________________ >
52
A L K A D L A P K Q V Q L K E V I  D K H I  S E Y>
______________________ TRANSLATION OF 50_1_F_E D IT  [C ]_____________________________>
500 5 1 0  520  530 540  550  560
CCGTACCCTGATGGATCCCATCCTCACCGAGTACTATGCCAAGCACACAGCTGACATGGAAGCCCTGAAG 
GGCATGGGACTACCTAGGGTAGGAGTGGCTCATGATACGGTTCGTGTGTCGACTGTACCTTCGGGACTTC 
P Y P D G S H P H R V L C Q A H S * H G S P E >
_____________________ TRANSLATION OF 50_1_F_E D IT  [B ]_____________________________>
R T L M D P I  L T E Y Y A K H T A D M E A L K>
______________________ TRANSLATION OF 50_1_F_E D IT  [C ]_____________________________ >
570  580  590  600 610 620 630
T T GAAGATGGAGC C CAT T GT GGAGGAGC T GCGTACCAAGAT T T C TAC CAACGT GGAGGAGAC CAAGAC C G 
AACTTCTACCTCGGGTAACACCTCCTCGACGCATGGTTCTAAAGATGGTTGCACCTCCTCTGGTTCTGGC 
V E D G A H C G G A A Y Q D F Y Q R G G D Q D  R>
______________________ TRANSLATION OF 50_1_F_E D IT  [B ]_____________________________>
L K M  E P I  V E E L R T K I  S T N V E E T K T>
______________________ TRANSLATION OF 50_1_F_E D IT  [C ]_____________________________>
640 650 660 670 680 690 700
CCCTGATGCCCATTGTGGAGTCTGTTCGCGACAAGCTCCAGGAGCGTCTTGAGAGCCTGAAGGCAATGGC 
GGGACTACGGGTAACACCTCAGACAAGCGCTGTTCGAGGTCCTCGCAGAACTCTCGGACTTCCGTTACCG 
P D A H C G V C S R Q A P G A S  * E P E G N  G>
______________________ TRANSLATION OF 50_1_F_E D IT  [B ]_____________________________ >
A L M P I  V E S V R D K L Q E R L E S L K A M A>
______________________ TRANSLATION OF 50_1_F_E D IT  [C ]_____________________________>
710 720  730
TAGT C CATAC CC T GAAGAATACAAGGAC CAGAT G 
ATCAGGTATGGGACTTCTTATGTTCCTGGTCTAC 
* S I P * R I Q G P D X >
 TRANSLATION OF 50_1_F _E D IT  _____ >
S P Y P E E Y K D Q M>
TRANSLATION OF 50 1 F EDIT >
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Figure 9
Aligned amino acid sequences using Mac Vector ClustalW. N-term = N-terminal 
sequence of 25kD protein recognized by mAB 6 D6 , 5’ = 5’ sequence from 5’ RACE, 3’ 
= sequence from 3’ RACE, clone 3 1  {no intron} = sequence of clone 3 1  obtained 
using genomic striped bass DNA without the intron, ApoAl 5 + 3 = composite sequence 
using 5’ and 3’ sequences from RACE.
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Figure 10
Aligned amino acid sequences using MacVector ClustalW. ApoAl 5+3 = striped bass 
combined sequences from 5 ’ and 3 ’ RACE, wtflounder = Pseudopleuronectes 
americanus (winter flounder) ApoA-I, cod = Gadus morhua, puffer = Takifugu rubripes, 
carp = Cyprinus carpio, b.trout = Salmo trutta trutta, r.trout = Oncorhychus mykiss, 
Salmon = Salmo salar, seabream = Spams aurata, zebrafish = Danio rerio, gorilla = 
Gorilla gorilla, dog = Canisfamiliaris, baboon = Papio hamadryas, and human = Homo 
sapiens. Dark grey highlighted = 100% identity, light grey = consensus match, and white 
= mismatch (color key from MacVector program). Notice highly-conserved proline 
residue indicated with arrows. The large dark arrow pointing to the right denotes the 
beginning of the coding region for the mature form of human ApoA-I. The pre and pro 
sequences are shown under the bold line and dotted line respectively. The sequence 
before the intron is called exon A and after the intron is exon B (Shoulders et al. 1983). 
Areas highlighted in blue are regions corresponding to human ApoA-I lipid binding 
regions. Areas highlighted in pink are regions corresponding to human ApoA-I LCAT 
binding regions (Frank and Marcel 2000).
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Figure 11
Growth curves for E. coli, Streptococcus sp., and M. marinum. Each species was diluted 
to 1 0 , 0 0 0  cells/ml in the appropriate medium and 1 0 0  pi in triplicate was added to wells 
o f a 96 well plate. Normalized optical density is shown in the figure for several different 
time points.
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Figure 12
Antibacterial activity o f purified ApoA-I against E. coli using a range o f ApoA-I 
concentrations. Growth inhibition was observed up to 90% of control at the highest 
concentration o f ApoA-I in assay 1 with initial concentration o f 5x l0 4  cells/ml. Growth 
o f treated wells is significantly different from control at concentrations higher than 7.8 
Hg/ml (One-way ANOVA p < 0.05, Dunnetts multiple comparison p < 0.05). Growth 
inhibition was observed up to 100% of control at concentrations o f 1000.0 and 75.0 
p,g/ml ApoA-I with initial concentration o f 5x10 cells/ml. Growth o f treated wells is 
significantly different from control at concentrations higher than 31.3 pg/ml ApoA-I 
(One-way ANOVA p < 0.05, Dunnetts multiple comparison p < 0.05).
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Figure 13
Growth (OD increase) over time for antibacterial assay 2 using E. coli at a starting 
concentration of 5x10 cells/ml. Optical Density (normalized) o f E. coli incubated with 
s250.0 p,g/ml ApoA-I was significantly reduced compared to 0 pg/ml ApoA-I control. 
No increase in optical density occurred at concentrations o f 1000.0, 750.0, and 500.0 
p-g/ml, therefore lines are superimposed on top of each other along the x-axis.
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Figure 14
Antibacterial activity o f purified striped bass ApoA-I against Streptococcus sp. using a
3
range o f ApoA-I concentrations and bacteria at an initial concentration o f 5x10 cells/ml 
The bold line at 1 represents 100% growth. Streptococcus sp. growth was significantly 
inhibited compared to control at concentrations o f ApoA-I greater than 250.0 pg/ml. 
Growth was 100% inhibited at concentrations of 1000.0, 750.0, and 500.0 jig/ml.
o
o
oo
o
o ofNlooo<N o00
[ 0 J J U 0 3 J 0  %  ^ IS U 3 Q  ]B 3 Ijd O
Ap
oA
I 
H
g/m
l
65
Figure 15
Growth (OD increase) over time for antibacterial assay 2 using Streptococcus sp.
Starting concentration o f the bacterium were 5x10 cells/ml. Optical density (normalized) 
o f Streptococcus sp. incubated with s  250.0 pg/ml ApoA-I was significantly reduced 
compared to 0 pg/ml ApoA-I control. No increase in optical density occurred at 
concentrations o f 1000.0, 750,0, and 500.0 pg/ml, therefore lines are superimposed on 
top of each other along the x-axis.
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Figure 16
Antibacterial activity o f purified ApoA-I against M. marinum using a range o f ApoA-I 
concentrations measured at different time points. Both assays had an initial concentration 
o f 5x103 cells/ml. There was significant inhibition (One-way ANOVA, p < 0.05; 
Dunnetts multiple comparison, p < 0.05) of growth compared to control at concentrations 
higher than 250.0 jig/ml for assay 1 and 500.0 frg/ml for assay 2. M. marinum growth 
was 100% inhibited in assay 1 at concentrations higher than 375.0 jig/ml and in assay 2 at 
concentrations higher than 1250.0 pig/ml.
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Figure 17
Growth (OD increase) over time for antibacterial assays 1 and 2 using M. marinum. 
Optical density (normalized) o f M. marinum incubated with s=31.3 p,g/ml ApoA-I and 
62.5 (ig/ml ApoA-I was significantly reduced compared to 0 frg/ml ApoA-I control in 
assays 1 and 2 respectively. No increase in optical density occurred at concentrations 
greater than 375.0 p,g/ml ApoA-I for assay 1, therefore lines are superimposed on top of 
each other along the x-axis.
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Figure 18
Striped bass weight measured over time. Striped bass juveniles obtained from the 
Edenton national fish hatchery for the diet study, were weighed at four different times. 
Day -53 was the day they arrived at VIMS, day 1 is the first day o f the study, day 45 is 
the 45th day of the study and day 120 is the last day of the diet study. There were no 
significant differences in growth between the high fat and low fat groups at any time- 
point. Error bars represent 2 times the standard error.
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Figure 19
ApoA-I levels (mg/ml) of high fat and low fat groups o f striped bass at three time points. 
There were no significant differences between groups or over time (Student’s T-test, 
ANOVA, p < 0.05). Error bars represent 2 times the standard error.
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Figure 20
(A) ApoA-I western blot of striped bass plasma from the diet study. The four lanes to the 
left of the line are ApoA-I standards (100, 200, 300, and 500 ng ApoA-I) and to the right 
are plasma samples (0 . 1  pi) loaded in duplicate from the high fat group on day 1 2 0 .
(B) ApoA-I western blot of striped bass plasma samples randomly selected from the 
ChesMMAP archives (2005). The four lanes to the left of the line are ApoA-I standards 
(100, 200, 300, and 500 ng ApoA-I) and to the right are plasma samples (0.1 pi) from ten 
different fish. Some values cannot be accurately quantified because they were above the 
highest standard, however using the standard curve ApoA-I concentrations as high as
12.0 mg/ml and as low as 0.5 mg/ml were calculated.
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Discussion
These studies present evidence o f the in vitro antibacterial activity of striped bass 
ApoA-I against E. coli, Streptococcus sp., and M. marinum. Our findings support the 
findings of Concha et al. (2004). In addition, we provide the first sequence information 
of striped bass ApoA-I and a method for screening ApoA-I plasma levels in striped bass 
via western blot.
The 275 amino acid striped bass ApoA-I sequence obtained from amplification by 
degenerate primers and RACE contains amino acid sequences highly conserved among 
teleost ApoA-I. In addition, it contains highly conserved proline residues spaced 22 and 
11 amino acids apart near the C-terminal end which are a characteristic o f all ApoA-I 
sequences, mammalian and teleost (Koppaka 2001). These highly conserved regions of 
Apo A-I sequences are responsible for generating the a-helical structure o f ApoA-I, 
which is necessary for its function (Frank and Marcel 2000; Segrest et al. 2000). While 
the striped bass Apo A-I nucleotide or amino acid sequence does not show much sequence 
similarity with mammals it does share the characteristic proline residues. These prolines 
cause the protein to kink into a curved shape allowing binding to lipid (Borhani et al. 
1997; Brouillette et al. 2001). To further confirm the isolation o f the Apo A-I protein, an 
N-terminal sequence matching Other Apo A-I sequences (E value = 10‘7) was obtained 
from the immunoreactive protein recognized by striped bass monoclonal 6 D 6 .
The striped bass Apo A-I protein sequence is not highly conserved at the primary 
structural level when compared to mammalian sequences, however it does resemble
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ApoA-I proteins at the secondary level. The 275 amino acid striped bass ApoA-I 
sequence was submitted to the Protein Prediction site (using the PHDsec program 
(http://cubic.bioc.columbia.edu/predictDroteinT The striped bass ApoA-I sequence 
submitted was predicted to have 96.5% alpha-helical content, consistent with ApoA-I 
proteins from humans o f 60-90% (Koppaka 2001).
ApoA-I enriched samples purified from striped bass plasma inhibit growth of E. 
coli, Streptococcus sp. and M. marinum in vitro. In previous work studying the 
antibacterial activity o f carp Apo A-I, a concentration o f 143 p,g/ml o f Apo A-I inhibited 
growth o f E. coli (at an initial concentration o f 5 x 104  cells/ml) by 50% (Concha et al. 
2004). Our studies were consistent with this carp study in that concentrations of ApoA-I 
greater than or equal to 125.0 p-g/ml inhibited growth o f E. coli (also at an initial 
concentration o f 5 x 104  cells/ml) by 50%. Therefore, striped bass Apo A-I inhibits 
growth o f E. coli at similar concentrations as carp ApoA-I. In addition, E. coli growth 
was significantly reduced from control when incubated with concentrations o f ApoA-I 
greater than 31.3 (after 5.5 hours) and 3.9 p-g/ml (after 10 hours) for assays 1 and 2 
respectively. E. coli growth was not completely inhibited except at concentrations of
1000.0 and 750.0 p,g/ml ApoA-I in assay 2, whereas concentrations o f greater than 500.0 
|Ag/ml and 250.0 qg/ml completely inhibited growth o f Streptococcus sp. and M  
marinum, respectively. The concentration where growth (OD) was inhibited by 50% for 
Streptococcus sp. were between 250-375 j^g/ml. The concentrations where growth (OD) 
was inhibited by 50% for M  marinum assay 1 was between 125-250 qg/ml and for assay 
2 was between 375-500 p.g/ml.
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Concentrations o f ApoA-I used in these assays were well below concentrations 
seen in the plasma o f captive (1-3 mg/ml) and wild (0.5 to greater than 5 mg/ml) striped 
bass used in this study. Apo A-I concentrations of striped bass samples ranged from 
roughly 0.5 to greater than 5.0 mg/ml in plasma whereas concentrations used in our 
assays were 1.5 mg/ml or less. Thus, concentrations used in these assays were lower than 
in vivo concentrations and produced dramatic bacterial growth inhibition in these three 
species, which included both gram positive and gram negative.
ApoA-I has been detected in epidermal cells of several species. Tarugi et al. 
(1991) determined that chick skin can synthesize and secrete ApoA-I. In addition, 
ApoA-I was detected in carp epidermis and epidermal mucus via immunohistochemistry 
as well as small amounts o f Apo A-I mRNA in the epidermal cells (Concha et al. 2003, 
2004). This suggests that Apo A-I could be synthesized and secreted by the epidermis 
either as nascent HDL particles or in a lipid-free form. The ApoA-I located in the mucus 
and epidermis could possibly play more of a role as a first line o f defense against bacteria 
than ApoA-I in the plasma. Antimicrobial peptides play an important role in defense of 
epithelia against invasion and coloniztion by pathogens (Schroeder 1999). The epithelia 
is the first line of defense against pathogens and therefore plays an important role in 
innate immunity.
While there has been much research indicating the possible role o f Apo A-I in 
innate immune resistance to microbes (Concha et al. 2003, 2004; Kane et al. 1979;
Owens et al. 1990; Srinivas et al. 1990,1991; Tada et al. 1993), no evidence has been 
provided for a mechanism of antimicrobial activity. Srinivas et al. (1991) suggests that 
the lipid-binding properties o f Apo A-I prevent cell fusion of the Herpes Simplex Virus.
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Only ApoA-I peptides not bound to lipids, but containing lipid-binding sites inhibited 
viral cell fusion. Owens et al. (1989 & 1990) founds similar results with Human 
Immunodeficiency Virus. Agawa et al (1991) have suggested that a synthesized basic 
amphipathic alpha-helical model peptide has antimicrobial activity against both Gram- 
positive and -negative bacteria due to formation o f ion channels in the bacterial 
membrane. The designed peptide 46 was long enough to span a lipid bilayer with 
transmembrane bundles of a-helices, had potent antimicrobial activities, and channel- 
forming abilities. Thus, the antimicrobial activity o f Apo A-I could be solely due to its 
amphipathic nature and high affinity for lipids and its a-helical structure.
Additional evidence that suggests amphipathic, alpha-helical, proteins have pore- 
forming properties is the lysis of the lysosomal membrane in the parasite Trypanosoma 
brucei, by human apolipoprotein L-I. This results in lysis o f the trypansome (ApoL-I) 
(Perez-Morga et al. 2005), ApoL-I is an amphipathic alpha-helical lipoprotein associated 
with ApoA-I containing HDL particles (Duchateau et al. 1997, 2001; Monajemi et al 
2002; Page et al. 2001; Poelvoorde et al. 2004). Lysis of the trypanosome involved 
uptake o f the HDL particle (with ApoL-I) into the lysosome o f the parasite. After this 
ApoL-I was co localized with the lysosomal membrane, forming an ion channel causing 
an influx of Cl' ions into the lysosome, which in turn caused a compensatory movement 
o f extracellular Cl' across the plasma membrane into the cytoplasm. The swelling of the 
lysosome compromised the physical integrity o f the trypanosome, which preceded lysis 
o f the trypanosome.
The antibacterial activity o f ApoA-I fragments has been investigated and Concha 
et al. (2004) have demonstrated the antibacterial activity in vitro o f a peptide analog to
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the C-terminus o f Apo A-I. An interesting feature o f this peptide is its ability to synergize 
with lysozyme to enhance growth inhibition (Concha et al. 2004). Lysozyme alone does 
not have an inhibitory effect at concentrations below 1 0 . 0  p.g/ml, however when 
combined with the peptide at less than lmM  concentration significant inhibition occurred 
(Concha et al. 2004). Several other antimicrobial peptides previously described also 
synergize with lysozymes (Singh et al 2000, Patrzykat 2001). Therefore, ApoA-I may 
not act alone. Many lysozymes are present in the epidermis o f fish (Fast et al. 2002) and 
Concha et al. (2003) has shown that ApoA-I is also produced in the skin of carp. The 
potential synergistic effect o f lysozyme and ApoA-I could be involved in innate 
immunity against microbes. Concha et al. (2004) also determined that the protease 
chymotrypsin could degrade ApoA-I into several stable fragments. Chymotrypsin used 
in this study has the same specificity as chymase, a protease released by mast cells after 
an insult (Lee et al. 2003, Eberini et al. 2002). Therefore it is possible that intact Apo A-I 
and peptide fragments generated by physiologically relevant proteases could play a role 
in innate immunity.
No significant differences in Apo A-I levels were found between juvenile striped 
bass fed a low-fat (0 % menhaden oil) diet versus a high-fat (8 % menhaden oil) diet. 
Lipoprotein patterns o f fishes are influenced by a number o f factors, among them: diet, 
time from last feeding, temperature, season and sexual stage (Kayama and Iijima 1976; 
Fremont et al., 1981; Fremont and Marion, 1982; Iijima et al., 1985; Leger 1985; Rogie 
and Skinner, 1985; Nakagawa et al., 1986; White et al., 1986; Hidalgo and Alliot, 1988; 
Santulli et al., 1988; MacFarlane et al., 1990). In this study, it is possible the diet did not 
differ enough in fat content, the fish did not feed well or were under stress, or fish
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differed in their stage of maturity. Wild striped bass demonstrated greater than 10-fold 
differences in ApoA-I concentrations therefore there is great variation in Apo A-I among 
striped bass.
There have been many studies o f Apo A-I regulation in mammals. In humans, a 
high fat diet increases levels o f ApoA-I and HDL (Mensink et al. 2003), however a diet 
high in polyunsaturated fat compared to saturated fat actually can actually lower plasma 
concentrations o f Apo A-I and HDL (Vessby et al. 1980). In studies with mice, increased 
Apo A-I production in response to dietary fat was not associated with any increase in 
hepatic or intestinal ApoA-I mRNA (Hayek et al. 1993). This suggests that the 
mechanism of the dietary fat effect was post-transcriptional. Possibly reduced 
degradation o f the Apo A-I protein or increased translatability of ApoA-I mRNA was the 
cause of the elevated ApoA-I levels in plasma.
At this point we cannot ensure that the antibacterial activity o f striped bass ApoA- 
I is physiologically relevant. Once the mechanism of antibacterial activity is ascertained 
it would be interesting to evaluate antibacterial activity in vivo.
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GENERAL CONCLUSIONS
Significance of this Thesis
This thesis demonstrates for the first time the in vitro antibacterial activity of purified 
striped bass ApoA-I. These results suggest that striped bass ApoA-I may play a role in 
striped bass resistance to bacteria. Additionally, this work supports findings of Concha et 
al. (2003) that carp ApoA-I has antibacterial activity in vitro.
Conclusions
1. Purified striped bass ApoA-I inhibits growth in vitro of E. coli, Streptococcus sp., and 
Mycobacterium marinum.
2. The striped bass (Morone saxatilis) genome contained an Apo A-I DNA sequence for 
the ApoA-I gene. The coding segment (1240 bp) of the gene was sequenced and encodes 
a 275 amino acid protein.
3. Striped bass ApoA-I shows highly conserved characteristics seen in all ApoA-I 
sequences (mammalian, and teleost) and is highly similar to that o f other teleost species.
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